Short Report on Baker Hughes Company Stock

By Kim Brooks • Tuesday, December 19 15:48 • Permanent Link

Large-cap Industrials company Baker Hughes Company has moved -0.1% so far today on a volume of 3,324,867, compared to its average of 7,025,058. In contrast, the S&P 500 index moved 0.0%.

Baker Hughes Company trades -17.73% away from its average analyst target price of $41.38 per share. The 25 analysts following the stock have set target prices ranging from $35.0 to $47.0, and on average have given Baker Hughes Company a rating of buy.

If you are considering an investment in BKR, you'll want to know the following:

Baker Hughes Company has moved 17.8% over the last year, and the S&P 500 logged a change of 24.0%
Based on its trailing earnings per share of 1.67, Baker Hughes Company has a trailing 12 month Price to Earnings (P/E) ratio of 20.4 while the S&P 500 average is 15.97
BKR has a forward P/E ratio of 16.7 based on its forward 12 month price to earnings (EPS) of $2.04 per share
The company has a price to earnings growth (PEG) ratio of 0.5 — a number near or below 1 signifying that Baker Hughes Company is fairly valued compared to its estimated growth potential
Its Price to Book (P/B) ratio is 2.25 compared to its sector average of 4.06
Baker Hughes Company provides a portfolio of technologies and services to energy and industrial value chain worldwide.
Based in Houston, the company has 57,000 full time employees and a market cap of $34.5 Billion. Baker Hughes Company currently returns an annual dividend yield of 2.3%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.